Innogen Summit India 2016

 Post Show Report 2nd Annual Food Quality & Safety India Congress 2015

Competition in the generics market is becoming increasingly intense. There is still room for growth in the more mature generics markets, with governments examining methods of increasing generic usage even further. Low competition & higher profitability seem to be the critical drivers for innovative generics.

Top line growth of the pharma business beyond 2016 is estimated nearly $1.4 trillion in drug sales by 2020. Two-thirds of the growth between 2012 and 2020 is forecasted to come from emerging countries, including BRICS. Approximately 50% of future global drug market growth will come from generics. And estimations are that the super generics can generate 7 to 10 times value of plain generics with all the top global generic players including the Indian companies having a ‘super-generic’ strategy in place and making investments accordingly.

We bring you Innogen Summit India 2016 designed to keep you up to date with the latest legislative, regulatory, and global developments in the generic marketplace, whilst providing networking opportunities with the key industry decision makers.


Key Topics of
Discussion Day 1

  • Why super-generics?
  • Market trends and outlook for Super generics
  • Developing capacities for a Super generic product pipeline
  • Innovative Techniques to develop New Therapeutic Entities (NTE’s)
  • Partnership strategies to drive innovation, product development and market take-up of advanced generics

Key Topics of
Discussion Day 2

  • Overcoming challenges faced with Regulatory compliance & approvals with US FDA & EMEA for Innovative generic drugs
  • Understanding the regulatory requirements for super-generic development and potential IP issues
  • Strategies for improving R&D returns
  • Improving the stability, solubility and bioavailability of formulations
  • Exploring biotechnology, nanosciences and nanotechnology as strategic’ areas for Generics scientific and commercial development

5 Key Reasons
to attend

  • Map out the latest emerging strategies that will help you develop a Super Generics drugs pipeline
  • Get an insight into how to broaden the value proposition and manage the value chain for Generics drugs
  • Understand the growing demand for innovative generic drugs/ super generic drugs
  • Share best practices on Innovation in Generics
  • Network with India’s top R&D, Formulation experts and C-level executives

Who will you meet?
Industry Professionals from the following functional roles:

  • Research & Development
  • Regulatory Affairs
  • Sales, Marketing & Business Development
  • Intellectual Property / Legal
  • Government Affairs
  • Market Access & Licensing
  • New Product Development
  • Quality Assurance
  • Procurement & Sourcing
  • Collaborative Research & Manufacturing

Who should attend?
Industries who will attend:

  • Generic Pharmaceutical Manufacturers
  • API Manufacturers& distributors
  • Regulatory consultants & service providers
  • Pharmaceutical Laboratories & Analytical centers
  • Pharmaceutical instrumentation providers
  • Formulation solution providers
  • Other product & service providers to the generic pharmaceutical industry